業績紹介
2020年 論文
- MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok K Wong, Mototsugu Oya, Donald Kufe.
Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. - Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.
Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake, Shingo Hatakeyama, Hiro-Omi Kanayama, Kazuyuki Numakura, Toshio Takagi, Tomoyuki Kato, Masatoshi Eto, Wataru Obara, Hirotsugu Uemura, Toni K Choueiri, Robert J Motzer, Yosuke Fujii, Yoichi Kamei, Yoshiko Umeyama, Alessandra di Pietro, Mototsugu Oya.
Cancer Sci. 2020 Mar;111(3):907-923. doi: 10.1111/cas.14294. Epub 2020 Feb 5. - Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies.
Nobuyuki Tanaka, Shigeaki Kanatani, Dagmara Kaczynska, Keishiro Fukumoto, Lauri Louhivuori, Tomohiro Mizutani, Oded Kopper, Pauliina Kronqvist, Stephanie Robertson, Claes Lindh, Lorand Kis, Robin Pronk, Naoya Niwa, Kazuhiro Matsumoto, Mototsugu Oya, Ayako Miyakawa, Anna Falk, Johan Hartman, Cecilia Sahlgren, Hans Clevers, Per Uhlén.
Nat Biomed Eng. 2020 Sep;4(9):875-888. doi: 10.1038/s41551-020-0576-z. Epub 2020 Jun 29. - Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
Yoshihiko Tomita, Tsunenori Kondo, Go Kimura, Takamitsu Inoue, Yoshiaki Wakumoto, Masahiro Yao, Takayuki Sugiyama, Mototsugu Oya, Yasuhisa Fujii, Wataru Obara, Robert J Motzer, Hirotsugu Uemura.
Jpn J Clin Oncol. 2020 Jan 24;50(1):12-19. doi: 10.1093/jjco/hyz132. - Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Yoshihiko Tomita, Katsunori Tatsugami, Noboru Nakaigawa, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Chihiro Nakayama Kondoh, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Shingo Tanaka, Akiko Kimura, Satoshi Tamada.
Int J Urol. 2020 Nov;27(11):952-959. doi: 10.1111/iju.14329. Epub 2020 Aug 12. - MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.
Masayuki Hagiwara, Yota Yasumizu, Nami Yamashita, Hasan Rajabi, Atsushi Fushimi, Mark D Long, Wei Li, Atrayee Bhattacharya, Rehan Ahmad, Mototsugu Oya, Song Liu, Donald Kufe.
Cancer Res. 2021 Feb 15;81(4):1111-1122. doi: 10.1158/0008-5472.CAN-20-2588. - Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Karim Fizazi, Matthew Smith, Neal Shore, Teuvo Tammela, Ken-Ichi Tabata, Nobuaki Matsubara, Masahiro Iinuma, Hirotsugu Uemura, Mototsugu Oya, Tetsuo Momma, Mutsushi Kawakita, Satoshi Fukasawa, Tadahiro Kobayashi, Iris Kuss , Marie-Aude Le Berre, Amir Snapir, Toni Sarapohja, Kazuhiro Suzuki.
Int J Clin Oncol. 2021 Mar;26(3):578-590. doi: 10.1007/s10147-020-01824-5. - Pyometra in a hemodialysis patient with severe constipation.
Kohkichi Morimoto, Tadashi Yoshida, Mototsugu Oya.
Clin Exp Nephrol. 2020 Sep;24(9):849. doi: 10.1007/s10157-020-01900-0. - A case of inguinal cellular angiofibroma.
Rei Kamitani, Kazuhiro Matsumoto, Shinnosuke Fujiwara, Hirotaka Akita, Shuji Mikami, Kaori Kameyama, Masahiro Jinzaki, Mototsugu Oya.
IJU Case Rep. 2020 Feb 20;3(2):69-71. doi: 10.1002/iju5.12147. eCollection 2020 Mar. - Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia.
Jun Hagiuda, Nobuyoshi Takasaki, Mototsugu Oya, Hiromichi Ishikawa, Hisashi Narimatsu.
Hum Fertil (Camb). 2020 Dec;23(4):226-233. doi: 10.1080/14647273.2018.1562239. Epub 2019 Jan 10. - Significance of tumor microenvironment in acquiring resistance to vascular endothelial growth factor-tyrosine kinase inhibitor and recent advance of systemic treatment of clear cell renal cell carcinoma.
Shuji Mikami, Ryuichi Mizuno, Takeo Kosaka, Nobuyuki Tanaka, Naoto Kuroda, Yoji Nagashima, Yasunori Okada, Mototsugu Oya.
Pathol Int. 2020 Oct;70(10):712-723. doi: 10.1111/pin.12984. Epub 2020 Jul 11. - Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines.
Stavros Gravas, Georges Fournier, Mototsugu Oya, Duncan Summerton, Roberto Mario Scarpa, Piotr Chlosta, Ioannis Gkialas, Li-Ping Xie, Nur Rasyid, Damien Bolton, Reynaldo Gomez, Laurence Klotz, Sanjay Kulkarni, Simon Tanguay, Jean de la Rosette, SIU Board of Directors.
Eur Urol Focus. 2020 Sep 15;6(5):1104-1110. doi: 10.1016/j.euf.2020.06.006. Epub 2020 Jun 15. - Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma.
Kimiharu Takamatsu, Toshikazu Takeda, Seiya Hattori, Nobuyuki Tanaka, Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Hiroshi Asanuma, Isao Kurihara, Hiroshi Itoh, Mototsugu Oya.
Clin Endocrinol (Oxf). 2020 Jun;92(6):503-508. doi: 10.1111/cen.14176. Epub 2020 Mar 3. - Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Toshikazu Takeda, Amy L Tin, Renato B Corradi, Ricardo Alvim, Takeshi Hashimoto, Yujiro Ito, Daniel P Nguyen, Maha Mamoor, Nicola L Robertson, Hebert A Vargas, Nicole E Benfante, Daniel D Sjoberg, James A Eastham, Peter T Scardino, Samson W Fine, Mototsugu Oya, Karim A Touijer.
Int J Urol. 2020 Feb;27(2):179-185. doi: 10.1111/iju.14161. Epub 2019 Dec 13. - Reduced recurrence of low-risk non-muscle-invasive bladder cancer is associated with low urine-specific gravity.
Tomohiro Iwasawa, Naoya Niwa, Kazuhiro Matsumoto, Akari Komatsuda, Hiroki Ide, Mototsugu Oya.
Int J Urol. 2020 Nov;27(11):1019-1023. doi: 10.1111/iju.14351. Epub 2020 Aug 13. - Umbilical closure using 2-octyl cyanoacrylate in transumbilical laparoscopic adrenalectomy: A randomized controlled trial.
Keishiro Fukumoto, Akira Miyajima, Kazuhiro Matsumoto, Hiroaki Kobayashi, Naoya Niwa, Hiroshi Hongo, Isao Kurihara, Eiji Kikuchi, Mototsugu Oya.
Int J Urol. 2020 Aug;27(8):670-675. doi: 10.1111/iju.14270. Epub 2020 Jun 1. - Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases.
Rei Kamitani, Kazuhiro Matsumoto, Toshikazu Takeda, Ryuichi Mizuno, Mototsugu Oya.
Int J Clin Oncol. 2020 Dec;25(12):2099-2106. doi: 10.1007/s10147-020-01753-3. Epub 2020 Jul 26. - Safety and efficacy of plasma exchange via direct femoral vein puncture in autoimmune blistering diseases.
Tadashi Yoshida, Hitoshi Minakuchi, Ryohei Takahashi, Shinya Morita, Mototsugu Oya.
J Clin Apher. 2020 Jun;35(3):172-177. doi: 10.1002/jca.21774. Epub 2020 Mar 6. - Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.
Keisuke Shigeta, Masanori Hasegawa, Eiji Kikuchi, Yota Yasumizu, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Akira Miyajima, Donald Kufe, Mototsugu Oya.
Cancer Sci. 2020 Oct;111(10):3639-3652. doi: 10.1111/cas.14574. Epub 2020 Aug 11. - Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma.
Nozomi Hayakawa, Eiji Kikuchi, Shigeaki Suzuki, Mototsugu Oya.
Int Cancer Conf J. 2020 Mar 21;9(3):123-126. doi: 10.1007/s13691-020-00408-4. eCollection 2020 Jul. - Can random bladder biopsies be eliminated after bacillus Calmette-Guérin therapy against carcinoma in situ?
Kimiharu Takamatsu, Kazuhiro Matsumoto, Eiji Kikuchi, Koichiro Ogihara, Nozomi Hayakawa, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Hiroshi Asanuma, Shuji Mikami, Masafumi Oyama, Mototsugu Oya.
Int Urol Nephrol. 2021 Mar;53(3):465-469. doi: 10.1007/s11255-020-02667-9. Epub 2020 Oct 6. - Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy.
Kazuhiro Matsumoto, Naoya Niwa, Masayuki Hagiwara, Takeo Kosaka, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Satoshi Hara, Hiroshi Asanuma, Mototsugu Oya.
World J Urol. 2020 Jul;38(7):1749-1756. doi: 10.1007/s00345-019-02970-w. Epub 2019 Sep 26. - External validation of the "optimal PSA follow-up schedule after radical prostatectomy" in a new cohort.
Yoshinori Yanai, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Nobuyuki Tanaka, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Hiroshi Asanuma, Mototsugu Oya.
Int J Clin Oncol. 2020 Jul;25(7):1393-1397. doi: 10.1007/s10147-020-01676-z. Epub 2020 Apr 13. - Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review.
Rei Kamitani, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Akinori Hashiguchi 3, Nobuyuki Tanaka 1, Shinya Morita 1, Ryuichi Mizuno 1, Toshiaki Shinojima 1, Hiroshi Asanuma 1, Mototsugu Oya.
Clin Genitourin Cancer. 2021 Feb;19(1):69-75.e5. doi: 10.1016/j.clgc.2020.08.001. Epub 2020 Aug 7. - Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC
Yoshihiko Tomita, Sei Naito, Naoto Sassa, Atsushi Takahashi, Tsunenori Kondo, Takuya Koie, Wataru Obara, Yasuyuki Kobayashi, Jun Teishima, Masayuki Takahashi, Hideyasu Matsuyama, Takeshi Ueda, Kenya Yamaguchi, Takeshi Kishida, Ryoichi Shiroki, Takashi Saika, Nobuo Shinoahara, Mototsugu Oya, Hiro-Omi Kanayama.
Clin Genitourin Cancer. 2020 Aug;18(4):e374-e385. doi: 10.1016/j.clgc.2020.01.001. Epub 2020 Mar 6. - Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: nationwide survey in Japan.
Teruo Inamoto, Haruhito Azuma, Katsunori Tatsugami, Mototsugu Oya, Masatoshi Adachi, Yutaka Okayama, Toshiyuki Sunaya, Hideyuki Akaza.
Expert Rev Anticancer Ther. 2020 Jul;20(7):615-623. doi: 10.1080/14737140.2020.1773805. Epub 2020 Jun 16. - Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.
Shinya Morita, Kazunobu Shinoda, Tadashi Yoshida, Masayuki Shimoda, Yoshihiko Kanno, Ryuichi Mizuno, Hidaka Kono, Hiroshi Asanuma, Ken Nakagawa, Kazuo Umezawa, Mototsugu Oya. - Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection.
Satoshi Yazawa, Naoki Hasegawa, Mototsugu Oya. - ASO Author Reflections: Discussing the Oncological Feasibility of Performing Pure Laparoscopic Radical Nephroureterectomy for Upper-Tract Urothelial Carcinoma Patients: Results from a Multi-institution Collaborative Study Adjusted by Propensity Score Matching.
Keisuke Shigeta, Kazuhiro Matsumoto, Mototsugu Oya.
Ann Surg Oncol. 2021 Jan;28(1):474-475. doi: 10.1245/s10434-020-09048-7. Epub 2020 Aug 19. - A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report.
Kota Umeda, Takeo Kosaka, Kohei Nakamura, Toshikazu Takeda, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya.
Diagn Pathol. 2020 Aug 6;15(1):102. doi: 10.1186/s13000-020-01016-9. - A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Keisuke Shigeta, Eiji Kikuchi, Takayuki Abe, Masayuki Hagiwara, Koichiro Ogihara, Tadatsugu Anno, Kota Umeda, Yuto Baba, Tansei Sanjo, Kazunori Shojo, Shuji Mikami, Ryuichi Mizuno, Mototsugu Oya.
Eur Urol Oncol. 2020 Dec;3(6):756-763. doi: 10.1016/j.euo.2019.06.021. Epub 2019 Aug 6. - CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression.
Yoshinori Yanai, Takeo Kosaka, Kohei Nakamura, Eriko Aimono, Kazuhiro Matsumoto, Shinya Morita, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya.
Cancer Sci. 2020 Dec;111(12):4652-4655. doi: 10.1111/cas.14672. Epub 2020 Oct 23. - The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm.
Keisuke Shigeta, Kazuhiro Matsumoto, Takayuki Abe, Akari Komatsuda, Toshikazu Takeda, Ryuichi Mizuno, Eiji Kikuchi, Hiroshi Asanuma, Yuki Arita, Hirotaka Akita, Masahiro Jinzaki, Akira Miyajima, Mototsugu Oya.
Asian J Surg. 2020 Jun;43(6):668-675. doi: 10.1016/j.asjsur.2019.09.002. Epub 2019 Oct 16. - Relationship between radiation doses and erectile function deterioration in patients with localized prostate cancer treated with permanent prostate brachytherapy
Keisuke Shigeta, Eiji Kikuchi, Masashi Matsushima, Koichiro Ogihara, Takeo Kosaka, Ryuichi Mizuno, Tomoki Tanaka, Naoyuki Shigematsu, Mototsugu Oya.
Int J Urol. 2020 Dec;27(12):1087-1093. doi: 10.1111/iju.14358. Epub 2020 Sep 6. - A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study.
Takamitsu Inoue, Masayoshi Miura, Masaaki Yanishi, Junya Furukawa, Fuminori Sato, Masahiro Nitta, Koji Yoshimura, Jun Hagiuda, Kazunobu Shinoda, Takashi Kobayashi, Akira Miyajima, Ken Nakagawa, Mototsugu Oya, Osamu Ogawa, Hiromitsu Mimata, Hiro-Omi Kanayama, Masato Fujisawa, Toshiro Terachi, Tadashi Matsuda, Tomonori Habuchi, LESS and RPS Research Group in Japanese Society of Endourology.
Surg Endosc. 2020 Aug;34(8):3424-3434. doi: 10.1007/s00464-019-07119-9. Epub 2019 Sep 23. - Factors affecting renal function preservation among patients not achieving trifecta after laparoscopic partial nephrectomy for clinical T1a renal masses.
Toshikazu Takeda, Akari Komatsuda, Yoshinori Yanai, Nobuyuki Tanaka, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Toshiaki Shinojima, Hiroshi Asanuma, Mototsugu Oya.
Asian J Endosc Surg. 2020 Oct;13(4):526-531. doi: 10.1111/ases.12776. Epub 2019 Dec 9. - Pulmonary metastasis secondary to abiraterone-resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case.
Mizuki Izawa, Takeo Kosaka, Kohei Nakamura, Junna Oba, Tomoyuki Hishida, Hiroshi Hongo, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya.
IJU Case Rep. 2020 Oct 15;4(1):14-17. doi: 10.1002/iju5.12224. eCollection 2021 Jan. - The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients.
Koichiro Ogihara, Eiji Kikuchi, Keisuke Shigeta, Takashi Okabe, Seiya Hattori, Ryo Yamashita, Shunsuke Yoshimine, Suguru Shirotake, Ryuto Nakazawa, Kazuhiro Matsumoto, Ryuichi Mizuno, Satoshi Hara, Masafumi Oyama, Takeshi Masuda, Masashi Niwakawa, Mototsugu Oya.
Urol Oncol. 2020 Jun;38(6):602.e1-602.e10. doi: 10.1016/j.urolonc.2020.02.005. Epub 2020 Mar 2. - Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients.
Hitoshi Minakuchi, Tadashi Yoshida, Noriko Kaburagi, Teppei Fujino, Sho Endo, Tomoko Yamashita Takemitsu, Norimasa Yamashita, Hiroshi Itoh, Mototsugu Oya.
Ren Fail. 2020 Nov;42(1):799-806. doi: 10.1080/0886022X.2020.1803085. - Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
Keiichi Ito, Shuji Mikami, Naoto Kuroda, Yoji Nagashima, Katsunori Tatsugami, Naoya Masumori, Tsunenori Kondo, Toshio Takagi, Shotaro Nakanishi, Masatoshi Eto, Tomomi Kamba, Yoshihiko Tomita, Hideyasu Matsuyama, Tomoyasu Tsushima, Hayakazu Nakazawa, Mototsugu Oya, Go Kimura, Nobuo Shinohara, Tomohiko Asano.
Jpn J Clin Oncol. 2020 Oct 22;50(11):1313-1320. doi: 10.1093/jjco/hyaa114. - Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching.
Keisuke Shigeta, Kazuhiro Matsumoto, Toshikazu Takeda, Seiya Hattori, Gou Kaneko, Masashi Matsushima, Takayuki Abe, Nobuyuki Tanaka, Ryuichi Mizuno, Hiroshi Asanuma, Eiji Kikuchi, Mototsugu Oya.
Ann Surg Oncol. 2021 Jan;28(1):465-473. doi: 10.1245/s10434-020-09046-9. Epub 2020 Aug 25. - Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report.
Hiroshi Hongo, Takeo Kosaka, Eriko Aimono, Hiroshi Nishihara, Mototsugu Oya.
Diagn Pathol. 2020 Jan 13;15(1):5. doi: 10.1186/s13000-019-0916-z. - Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study.
Shigeru Sugiyama, Kazuo Sato, Yoshiyuki Shibasaki, Yutaka Endo, Taku Uryu, Yasuharu Toyoshima, Mototsugu Oya, Naoto Miyanaga, Nagahiro Saijo, Akihiko Gemma, Hideyuki Akaza.
Jpn J Clin Oncol. 2020 Aug 4;50(8):940-947. doi: 10.1093/jjco/hyaa062. - Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
Yuki Arita, Keisuke Shigeta, Hirotaka Akita, Tatsuya Suzuki, Ryohei Kufukihara, Thomas C Kwee, Ryota Ishii, Shuji Mikami, Shigeo Okuda, Eiji Kikuchi, Mototsugu Oya, Masahiro Jinzaki.
Eur Radiol. 2021 Feb;31(2):875-883. doi: 10.1007/s00330-020-07153-5. Epub 2020 Aug 23. - Physical Parameters, Use of Specific Medical Treatments, Nursing Levels, and Activities of Daily Living Are Potential Indicators for Forgoing Maintenance Hemodialysis.
Nobuko Yamaguchi, Tadashi Yoshida, Miho Oba, Reiko Nakano, Miwa Saito, Mihoko Hirokawa, Tazuru Shinmi, Chisa Urasawa, Mototsugu Oya.
Keio J Med. 2020 Mar 25;69(1):16-25. doi: 10.2302/kjm.2019-0001-OA. Epub 2019 May 9. - Successful perinatal management of a dichorionic diamniotic twin pregnancy in an anaemic kidney transplant patient treated with Darbepoetin alfa: a case report.
Satoshi Tamaki, Kazunobu Shinoda, Tadashi Matsumoto, Shinya Morita, Hiroshi Asanuma, Tadashi Yoshida, Mototsugu Oya.
J Obstet Gynaecol. 2020 Apr;40(3):427-429. doi: 10.1080/01443615.2019.1636776. Epub 2019 Sep 3. - Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report.
Kazunobu Shinoda, Shinya Morita, Satoshi Tamaki, Ryohei Takahashi, Sotaro Kitaoka, Hiroshi Asanuma, Tadashi Yoshida, Mikio Okayama, Hidenori Kasahara, Shinichiro Okamoto, Mototsugu Oya.
